GL1X · GenesisL1 explorer

UniProt Q96SB4

SRSF protein kinase 1 (Q96SB4)

SRSF protein kinase 1 (UniProt Q96SB4), EC 2.7.11.1: 11 experimental structures and 1 predicted model on GenesisL1, 4 ligands bound, 28 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
Q96SB4
Protein
SRSF protein kinase 1
EC
2.7.11.1
Experimental structures
11
Predicted models
1
Ligands
4
Pockets
28 · 4 records with a druggable one

Structures

12 records of Q96SB4 in the MolNFT archive: 11 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1WAKX-ray structure of SRPK1x-ray diffractionA——
1WAKX-ray structure of SRPK1x-ray diffractionA——
3BEGCrystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2x-ray diffractionA——
3BEGCrystal structure of sr protein kinase 1 complexed to its substrate ASF/SF2x-ray diffractionA——
4WUACrystal structure of human SRPK1 complexed to an inhibitor SRPIN340x-ray diffractionA——
4WUACrystal structure of human SRPK1 complexed to an inhibitor SRPIN340x-ray diffractionA——
5MY8Crystal structure of SRPK1 in complex with SPHINX31x-ray diffractionARXZ3 (best 0.71)
5MY8Crystal structure of SRPK1 in complex with SPHINX31x-ray diffractionARXZ—
6FADSR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27x-ray diffractionA, B, C, DPO413 (best 0.81)
6FADSr protein kinase 1 (SRPK1) in complex with the rgg-box of HSV1 ICP27x-ray diffractionA, B, C, DPO4—
7ZKSSRPK1 in complex with inhibitorx-ray diffractionAIXQ, CL3 (best 0.76)
Q96SB4AlphaFold monomer V2.0 prediction for srsf protein kinase 1 (Q96SB4)predictedA—9 (best 0.81)

Ligands

  • PO4 · Phosphate ion · in 2 records
  • RXZ · Sphinx31 · in 2 records
  • CL · Chloride ion · in 1 record
  • IXQ · N-[3-[[[2-(6-chloranyl-5-fluoranyl-1H-benzimidazol-2-yl)pyrimidin-4-yl]amino]methyl]pyridin-2-yl]-N-methyl-methanesulfonamide · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.